Chapter title |
Virus-Based Cancer Therapeutics for Targeted Photodynamic Therapy
|
---|---|
Chapter number | 41 |
Book title |
Virus-Derived Nanoparticles for Advanced Technologies
|
Published in |
Methods in molecular biology, January 2018
|
DOI | 10.1007/978-1-4939-7808-3_41 |
Pubmed ID | |
Book ISBNs |
978-1-4939-7806-9, 978-1-4939-7808-3
|
Authors |
Binrui Cao, Hong Xu, Mingying Yang, Chuanbin Mao, Cao, Binrui, Xu, Hong, Yang, Mingying, Mao, Chuanbin |
Abstract |
Cancer photodynamic therapy (PDT) involves the absorption of light by photosensitizers (PSs) to generate cytotoxic singlet oxygen for killing cancer cells. The success of this method is usually limited by the lack of selective accumulation of the PS at cancer cells. Bioengineered viruses with cancer cell-targeting peptides fused on their surfaces are great drug carriers that can guide the PS to cancer cells for targeted cancer treatment. Here, we use cell-targeting fd bacteriophages (phages) as an example to describe how to chemically conjugate PSs (e.g., pyropheophorbide-a (PPa)) onto a phage particle to achieve targeted PDT. |
Twitter Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Germany | 1 | 25% |
France | 1 | 25% |
Unknown | 2 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 19 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 5 | 26% |
Student > Master | 3 | 16% |
Student > Doctoral Student | 2 | 11% |
Student > Bachelor | 1 | 5% |
Student > Ph. D. Student | 1 | 5% |
Other | 2 | 11% |
Unknown | 5 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 2 | 11% |
Medicine and Dentistry | 2 | 11% |
Immunology and Microbiology | 2 | 11% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 5% |
Agricultural and Biological Sciences | 1 | 5% |
Other | 2 | 11% |
Unknown | 9 | 47% |